Mary Cabell Jonas

Geisinger Clinic

$972,083

Attributed

$2,916,250

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $884.1K · FY2020–23

$1M$750K$500K$250K$0

'20

'21

'22

'23

Funding mix

By agency

NIH$2,916,250 · 1

By mechanism

U01$2,916,250 · 1

Top collaborators

Most similar at Geisinger Clinic

Same institution · by research overlap

David H. Ledbetter$20,696,281
Christa Lese Martin$18,317,283
Marc S. Williams$13,191,603
Alanna K Rahm$4,444,561
Samuel S Gidding$2,021,664

Others in their field

Other Emerging Leaders on “Hereditary Malignant Neoplasm”

Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research$4,078,820
Alanna K Rahm · Geisinger Clinic$3,790,814
Michael F. Berger · Sloan-Kettering Inst Can Research$3,546,166
Sarah Knerr · University Of Washington$3,160,433
Jessica Ezzell Hunter · Kaiser Foundation Research Institute$3,158,276
Siddhartha Jaiswal · Stanford University$2,365,500

Research focus

Hereditary Malignant NeoplasmCancer EtiologyHealth Insurance Portability And Accountability ActHereditary Breast And Ovarian Cancer SyndromeCessation Of LifeClinical ProtocolsHealthcare SystemsCancer PatientCenters For Disease Control And Prevention (U.S.)ComplementComplexDiagnosisEducational WorkshopEffectivenessCommunicationCancer DiagnosisFamilyFamily MemberFeasibility StudiesGeneticGenetic TestingGenomicsGuidelinesImplementation Science

Grant awards (4)

Feasibility and Assessment of a Cascade Traceback Screening program - FACTS$658,560

U01 · FY2023 · CA

Feasibility and Assessment of a Cascade Traceback Screening program - FACTS$884,052

U01 · FY2022 · CA

Feasibility and Assessment of a Cascade Traceback Screening program - FACTS$670,622

U01 · FY2021 · CA

Feasibility and Assessment of a Cascade Traceback Screening program - FACTS$703,016

U01 · FY2020 · CA